| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arch Therapeutics, Inc. | Director | Common Stock | 10.3K | $2.83K | $0.28 | Aug 31, 2023 | Drake Partners |
| Arch Therapeutics, Inc. | Director | Stock Option (right to buy) | 250K | Nov 10, 2022 | Direct | ||
| Arch Therapeutics, Inc. | Director | Warrants (right to buy) | 20.6K | Aug 31, 2023 | Drake Partners |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ARTH | Arch Therapeutics, Inc. | Aug 31, 2023 | 2 | $2.83K | 4 | Sep 8, 2023 | Director |
| ARTH | Arch Therapeutics, Inc. | Nov 10, 2022 | 1 | $0 | 4 | Nov 10, 2022 | Director |
| ARTH | Arch Therapeutics, Inc. | Jul 6, 2022 | 3 | $0 | 4 | Jul 8, 2022 | Director |
| ARTH | Arch Therapeutics, Inc. | Sep 27, 2021 | 1 | $0 | 4 | Oct 13, 2021 | Director |
| ARTH | Arch Therapeutics, Inc. | Sep 27, 2021 | 0 | $0 | 3 | Oct 12, 2021 | Director |